ES2102417T3 - 9-aminotetrahidroacridinas y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos. - Google Patents

9-aminotetrahidroacridinas y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.

Info

Publication number
ES2102417T3
ES2102417T3 ES92102332T ES92102332T ES2102417T3 ES 2102417 T3 ES2102417 T3 ES 2102417T3 ES 92102332 T ES92102332 T ES 92102332T ES 92102332 T ES92102332 T ES 92102332T ES 2102417 T3 ES2102417 T3 ES 2102417T3
Authority
ES
Spain
Prior art keywords
hydrogen
loweralkyl
preparation
related compounds
aminotetrahydroacridines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92102332T
Other languages
English (en)
Inventor
Gregory Michael Shutske
Kevin James Kapples
John Dick Tomer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of ES2102417T3 publication Critical patent/ES2102417T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • C07D219/10Nitrogen atoms attached in position 9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/12Organo silicon halides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

ESTA INVENCION SE REFIERE A 9-AMINO-1, 2, 3, 4-TETRAHIDROACRIDINAS Y COMPUESTOS RELACIONADOS DE FORMULA 1, EN DONDE Y ES C=0 O CHOH; R ELEVADO 1 ES HIDROGENO O ALQUILO BAJO; R (AL CUADRADO) ES HIDROGENO, ALQUILO BAJO, O FENILBAJOALQUILO; R ELEVADO 3 ES HIDROGENO, OR ELEVADO 4 EN DONDE R ELEVADO 4 ES HIDROGENO O COR ELEVADO 5 ES ALQUILO BAJO; X ES HIDROGENO, ALQUILO BAJO, HALOGENO, ALCOXI BAJO, HIDROXI, O TRIFLUORMETIL, SUS ISOMEROS OPTICOS O GEOMETRICOS, N-OXIDOS DE LOS ANTERIORES, O LAS SALES DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLE DE LO ANTERIOR, QUE SON UTILES EN EL ALIVIO DE LAS DISFUNCIONES DE LA MEMORIA Y SON, POR LO TANTO INDICADAS EN EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER. ESTA INVENCION ADEMAS SE REFIERE A UN PROCESO PARA LA PREPARACION DE LOS COMPUESTOS ANTERIORES.
ES92102332T 1991-02-13 1992-02-12 9-aminotetrahidroacridinas y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos. Expired - Lifetime ES2102417T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/654,691 US5210087A (en) 1991-02-13 1991-02-13 9-aminotetrahydroacridines and related compounds

Publications (1)

Publication Number Publication Date
ES2102417T3 true ES2102417T3 (es) 1997-08-01

Family

ID=24625869

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92102332T Expired - Lifetime ES2102417T3 (es) 1991-02-13 1992-02-12 9-aminotetrahidroacridinas y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.

Country Status (25)

Country Link
US (3) US5210087A (es)
EP (1) EP0499231B1 (es)
JP (1) JPH07121915B2 (es)
KR (1) KR100223132B1 (es)
AT (1) ATE153331T1 (es)
AU (1) AU664165B2 (es)
BR (1) BR9200475A (es)
CA (1) CA2061084A1 (es)
CZ (1) CZ281927B6 (es)
DE (1) DE69219801T2 (es)
DK (1) DK0499231T3 (es)
ES (1) ES2102417T3 (es)
FI (2) FI96308C (es)
GR (1) GR3024310T3 (es)
HU (1) HU219451B (es)
IE (1) IE920459A1 (es)
IL (3) IL100921A (es)
MX (1) MX9200607A (es)
NO (1) NO177933C (es)
NZ (3) NZ260694A (es)
PL (6) PL168862B1 (es)
RO (1) RO112354B1 (es)
RU (1) RU2083564C1 (es)
TW (1) TW221426B (es)
ZA (1) ZA921004B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210087A (en) * 1991-02-13 1993-05-11 Hoechst-Roussel Pharmaceuticals Inc. 9-aminotetrahydroacridines and related compounds
ES2059263B1 (es) * 1992-10-27 1995-10-01 Vita Invest Sa Procedimiento para la obtencion del (+)-9-amino-1,2,3,4-tetrahidroacridin-1-ol.
US5434170A (en) * 1993-12-23 1995-07-18 Andrulis Pharmaceuticals Corp. Method for treating neurocognitive disorders
ES2144353B1 (es) * 1997-12-26 2001-01-01 Consejo Superior Investigacion Nuevos analogos de tacrina: potenciales agentes neuroprotectores para las enfermedades de alzheimer y parkinson. su procedimiento de obtencion.
EP1484325B1 (en) * 2002-03-08 2014-06-18 Japan Science and Technology Agency Isoxazole derivatives and process for producing the same
RU2616247C1 (ru) * 2016-03-28 2017-04-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинский государственный университет имени Коста Левановича Хетагурова" (СОГУ) Твердая лекарственная форма, обладающая холинопозитивным действием, на основе 9-бутиламино-3,3-диметил-1,2,4-тригидроакридина

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232945A (en) * 1962-08-13 1966-02-01 S E Massengill Company 7,8,9,10-tetrahalo-6h-cyclohepta-(b)-quinolines
EP0179383B1 (en) * 1984-10-25 1991-05-29 Hoechst-Roussel Pharmaceuticals Incorporated 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments
US4631286A (en) * 1984-10-25 1986-12-23 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
US4695573A (en) * 1984-10-25 1987-09-22 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
WO1989002739A1 (en) * 1987-10-05 1989-04-06 Pfizer Inc. 4-aminopyridine derivatives
GB8827704D0 (en) * 1988-11-28 1988-12-29 Fujisawa Pharmaceutical Co New acridine derivatives & processes for their production
US5441727A (en) * 1989-06-21 1995-08-15 The Procter & Gamble Company Diketone deodorant composition and method of deodorization
US5053513A (en) * 1990-03-29 1991-10-01 Hoechst-Roussel Pharmaceuticals Incorporated Method of reducing a carbonyl containing acridine
US5210087A (en) * 1991-02-13 1993-05-11 Hoechst-Roussel Pharmaceuticals Inc. 9-aminotetrahydroacridines and related compounds
GB2264707A (en) * 1991-06-18 1993-09-08 Roger Michael Marchbanks Acridine derivatives for treating alzheimer's disease

Also Published As

Publication number Publication date
DE69219801D1 (de) 1997-06-26
GR3024310T3 (en) 1997-10-31
JPH07121915B2 (ja) 1995-12-25
HU9200423D0 (en) 1992-04-28
FI97056B (fi) 1996-06-28
CA2061084A1 (en) 1992-08-14
NO920547L (no) 1992-08-14
US5382594A (en) 1995-01-17
AU664165B2 (en) 1995-11-09
FI97056C (fi) 1996-10-10
EP0499231A1 (en) 1992-08-19
JPH04312578A (ja) 1992-11-04
RO112354B1 (ro) 1997-08-29
EP0499231B1 (en) 1997-05-21
CZ281927B6 (cs) 1997-04-16
FI96308B (fi) 1996-02-29
NO920547D0 (no) 1992-02-12
RU2083564C1 (ru) 1997-07-10
TW221426B (es) 1994-03-01
PL168153B1 (pl) 1996-01-31
FI920566A (fi) 1992-08-14
DK0499231T3 (da) 1997-12-01
US5502203A (en) 1996-03-26
PL166939B1 (pl) 1995-07-31
FI920566A0 (fi) 1992-02-11
AU1090392A (en) 1992-08-20
PL168861B1 (pl) 1996-04-30
FI945854A0 (fi) 1994-12-13
ATE153331T1 (de) 1997-06-15
BR9200475A (pt) 1992-10-20
CS42692A3 (en) 1992-09-16
FI96308C (fi) 1996-06-10
PL296320A1 (en) 1993-07-12
ZA921004B (en) 1992-10-28
NZ260694A (en) 1996-02-27
IL117795A0 (en) 1996-08-04
NZ241586A (en) 1996-02-27
US5210087A (en) 1993-05-11
DE69219801T2 (de) 1997-11-27
FI945854A (fi) 1994-12-13
PL168862B1 (pl) 1996-04-30
MX9200607A (es) 1992-11-30
KR100223132B1 (ko) 1999-10-15
KR920016426A (ko) 1992-09-24
IE920459A1 (en) 1992-08-12
NO177933C (no) 1995-12-20
PL293443A1 (en) 1993-03-08
IL117795A (en) 1998-01-04
HUT67032A (en) 1995-01-30
PL168906B1 (pl) 1996-05-31
HU219451B (hu) 2001-04-28
NO177933B (no) 1995-09-11
PL296319A1 (en) 1993-07-12
IL100921A (en) 1998-12-27
PL169095B1 (pl) 1996-05-31
NZ270647A (en) 1996-02-27

Similar Documents

Publication Publication Date Title
HUT45503A (en) Process for producing alpha-alkyl-(4-amino-3-quinolinyl)-methanols, 1-/4-(aralkyl-amino)-3-quinolinyl/-alkanones and pharmaceutics comprising these compounds as active ingredient
FI93117C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinijohdannaisten valmistamiseksi
ES2102417T3 (es) 9-aminotetrahidroacridinas y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.
IL92233A0 (en) 1,2,3,4-tetrahydro-1,9-acridinediamines,a process for their preparation and their use as pharmaceutical compositions
FI895605A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 3a,4,5,6-tetrahydro-(3H)-pyrimidino/4,5,6-k,l/akridiinien valmistamiseksi
ES2072334T3 (es) Derivados de 4,5,5a,6-tetrahidro-3h-isoxazolo(5,4,3-kl)acridinas, un procedimiento para su preparacion y su uso como medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 499231

Country of ref document: ES